The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDH.L Regulatory News (IDH)

  • There is currently no data for IDH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Full Year Trading Update

25 Apr 2016 07:00

RNS Number : 1379W
Immunodiagnostic Systems Hldgs PLC
25 April 2016
 



 

 

 

 

Full year trading update

 

Immunodiagnostic Systems Holdings PLC

25 April 2016

 

 

 

 

 

 

25 April 2016

 

Immunodiagnostic Systems Holdings plc Trading Update for year ended 31 March 2016

 

Immunodiagnostic Systems Holdings plc ("the Group"), a specialist solution provider to the clinical laboratory diagnostic market, today provides a trading update for the year ended 31 March 2016.

 

Total revenues are expected to be c. £39 million (2015: £45 million), in line with the guidance given in November 2015. The decrease in revenues year on year is mainly due to further reductions in our manual assay business, where test volumes continue to migrate to automated solutions offered by us and others. In addition, we are continuing to lose automated 25-OH Vitamin D business as the larger laboratories migrate test volumes previously run on the iSYS analyzer to workhorses (i.e. high-throughput analyzers) when their contracts with IDS come due for renewal. These revenue trends are expected to continue into the current financial year.

 

Gross direct instrument placements were 31 (2015: 54) with 43 instruments returned in the year (2015: 40), meaning net direct instrument returns were 12 (2015: net additions of 14). The total number of instruments sold to or placed with distributors or OEM partners (net) during the year was 35 (2015: 49).

 

Closing cash and cash equivalents were £26.6 million at 31 March 2016 (31 March 2015: £23.7 million; 30 September 2015: £23.5million).

At the end of the year the company employed 315 people on a full time employment basis (FY 2015:346).

We are expecting a significant asset write-down of goodwill and capitalized costs in the year ended 31 March 2016 accounts. This write down will not impact the Group's cashflow.

 

Preliminary results for the year ended 31 March 2016 will be announced on 22 June 2016.

 

For further information:

 

Immunodiagnostic Systems Holdings plc Tel : +44 (0)191 5190660

Patricio Lacalle, Chief Executive Officer

Paul Martin, Group Finance Director

 

 

Peel Hunt LLP Tel : +44 (0)207 418 8900

James Steel

Oliver Jackson

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFVDSEIFFIR
Date   Source Headline
14th Dec 20127:00 amRNSDirectorate Change
12th Dec 20124:00 pmRNSHolding(s) in Company
12th Dec 20127:00 amRNSHolding(s) in Company
10th Dec 20126:08 pmRNSHolding(s) in Company
30th Nov 20126:15 pmRNSDirector/PDMR Shareholding
26th Nov 20127:00 amRNSHalf Yearly Report
24th Oct 201210:59 amRNSNotice of Results
19th Oct 20127:00 amRNSDirectorate Change Update
17th Oct 201211:41 amRNSSettlement on Escalon debt
1st Oct 201210:31 amRNSHolding(s) in Company
17th Sep 201212:54 pmRNSRedirectorate
14th Sep 20126:09 pmRNSAGM Result
14th Sep 20127:00 amRNSAGM Statement
15th Aug 20127:00 amRNSBoard Change
3rd Aug 20122:33 pmRNSDirector/PDMR Shareholding
30th Jul 201210:18 amRNSHolding(s) in Company
27th Jul 20129:29 amRNSHolding(s) in Company
27th Jul 20129:24 amRNSHolding(s) in Company
26th Jul 201210:30 amRNSAnnual Report and Accounts & Notice of AGM
2nd Jul 20127:00 amRNSDirectorate Change
25th Jun 20127:00 amRNSFinal Results
14th Jun 20127:00 amRNSProduct Launch
23rd Apr 201211:02 amRNSIDS Receives Prestigious Queens Award
12th Apr 20127:00 amRNSTrading Statement
4th Apr 20129:56 amRNSHolding(s) in Company
4th Apr 20127:00 amRNS1,25-Dihydroxy Vitamin D Assay Launch
14th Feb 20127:00 amRNSFDA clearance for a new specialist assay
9th Feb 20127:00 amRNSChange of Adviser
1st Feb 20123:16 pmRNSChange of Adviser
30th Jan 20128:27 amRNSDirector/PDMR Shareholding - Replacement
30th Jan 20127:00 amRNSDirector/PDMR Shareholding
30th Jan 20127:00 amRNSDirector/PDMR Shareholding
27th Jan 20127:00 amRNSDirector/PDMR Shareholding
24th Jan 20123:18 pmRNSHolding(s) in Company
24th Jan 20122:38 pmRNSHolding(s) in Company
23rd Jan 20127:01 amRNSTrading update
12th Jan 201212:13 pmRNSHolding(s) in Company
15th Dec 201111:02 amRNSHolding(s) in Company
30th Nov 20115:23 pmRNSTotal Voting Rights
28th Nov 20117:00 amRNSInterim Results
14th Nov 20112:03 pmRNSIssue of Equity
6th Oct 20117:00 amRNSTrading Update
4th Oct 20112:45 pmRNSHolding(s) in Company
8th Sep 20115:22 pmRNSResult of AGM
8th Sep 20117:00 amRNSAGM Statement
31st Aug 20114:35 pmRNSPrice Monitoring Extension
30th Aug 20117:00 amRNSDirectorate Change
25th Jul 20117:00 amRNSDirectorate Change
29th Jun 20114:50 pmRNSExercise of Options & Total Voting Rights
27th Jun 20117:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.